Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Living Cell Technologies ( (AU:1AI) ) has provided an announcement.
Algorae Pharmaceuticals Limited has announced a proposed issue of securities, specifically options expiring on December 1, 2029. This non-renounceable pro rata issue is set to offer a maximum of 337,678,946 securities, with key dates including an ex-date of November 26, 2025, a record date of November 27, 2025, and an issue date of December 22, 2025. The announcement signifies a strategic move by Algorae Pharmaceuticals to potentially raise capital, which could impact its market positioning and provide stakeholders with investment opportunities.
More about Living Cell Technologies
Average Trading Volume: 2,838,828
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$15.2M
For an in-depth examination of 1AI stock, go to TipRanks’ Overview page.